✦ LIBER ✦

Evidence-based evolution of the MELD/PELD liver allocation policy

✍ Scribed by Russell H. Wiesner

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 49 KB
Volume: 11
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20362

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overview of the MELD / PELD system of li

Overview of the MELD / PELD system of liver allocation indications for liver transplantation in the MELD era: Evidence-based patient selection

✍ Richard B. Freeman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Summary report of a national conference:

Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era

✍ Kim M. Olthoff; Robert S. Brown Jr.; Francis L. Delmonico; Richard B. Freeman; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy

✍ Francis Y. Yao; Nathan M. Bass; Nancy L. Ascher; John P. Roberts 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

We examined the impact of the Model for End-Stage Liver Disease (MELD) organ allocation scheme on 44 patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver transplantation (OLT) between February 2002 and January 2003, and compared the outcome with 58 patients listed in the 4 years be

MELD / PELD and the allocation of deceas

MELD / PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease

✍ Russell H. Wiesner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Key Points 1. Historical perspective of donor allocation to patients with fulminant hepatic failure (FHF). 2. Predicting prognosis in patients with FHF using the London and Clichy criteria. 3. Model for end-stage liver disease (MELD) is a predictor of mortality in patients with FHF. 4. Outcomes